| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 3 |
| NetGPI | no | yes: 0, no: 3 |
Related structures:
AlphaFold database: A4I6V9
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.714 |
| DOC_MAPK_MEF2A_6 | 24 | 31 | PF00069 | 0.494 |
| DOC_MAPK_MEF2A_6 | 41 | 50 | PF00069 | 0.687 |
| DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.729 |
| DOC_WW_Pin1_4 | 88 | 93 | PF00397 | 0.583 |
| LIG_14-3-3_CanoR_1 | 49 | 59 | PF00244 | 0.703 |
| LIG_14-3-3_CterR_2 | 98 | 101 | PF00244 | 0.661 |
| LIG_FHA_1 | 24 | 30 | PF00498 | 0.734 |
| LIG_FHA_1 | 54 | 60 | PF00498 | 0.701 |
| LIG_NRP_CendR_1 | 98 | 101 | PF00754 | 0.661 |
| MOD_CDK_SPK_2 | 88 | 93 | PF00069 | 0.583 |
| MOD_CK1_1 | 11 | 17 | PF00069 | 0.739 |
| MOD_CK1_1 | 23 | 29 | PF00069 | 0.539 |
| MOD_GlcNHglycan | 63 | 69 | PF01048 | 0.729 |
| MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.594 |
| MOD_GSK3_1 | 7 | 14 | PF00069 | 0.706 |
| MOD_NEK2_1 | 7 | 12 | PF00069 | 0.718 |
| MOD_Plk_1 | 8 | 14 | PF00069 | 0.716 |
| MOD_Plk_4 | 55 | 61 | PF00069 | 0.705 |
| MOD_Plk_4 | 8 | 14 | PF00069 | 0.716 |
| MOD_ProDKin_1 | 88 | 94 | PF00069 | 0.584 |
| TRG_DiLeu_BaEn_1 | 55 | 60 | PF01217 | 0.663 |
| TRG_Pf-PMV_PEXEL_1 | 5 | 9 | PF00026 | 0.714 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3S7X4K5 | Leishmania donovani | 96% | 100% |
| Q4Q677 | Leishmania major | 85% | 100% |